OXY
50
-2
AA
29
-2
PH
69
-2
MPC
49
-6
PYPL
45
-2
DFS
53
6
CNP
49
-8
EIX
50
2
CSCO
53
2
BAC
44
2
MHK
46
12
GM
60
11
BDX
46
11
BK
61
3
CSX
43
2
KMX
47
9
CHRW
39
3
EL
50
7
JWN
53
5
LEG
32
3
OXY
50
-2
AA
29
-2
PH
69
-2
MPC
49
-6
PYPL
45
-2
DFS
53
6
CNP
49
-8
EIX
50
2
CSCO
53
2
BAC
44
2
MHK
46
12
GM
60
11
BDX
46
11
BK
61
3
CSX
43
2
KMX
47
9
CHRW
39
3
EL
50
7
JWN
53
5
LEG
32
3
Financhill
Back

Cogent Biosciences 10K Form

Sell
32

COGT
Cogent Biosciences

Last Price:
6.65
Seasonality Move:
156.05%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-08-10 10Q COGT/Cogent Biosciences Quarterly
2020-05-11 10Q COGT/Cogent Biosciences Quarterly
2020-03-13 10K COGT/Cogent Biosciences Annual
2019-11-12 10Q COGT/Cogent Biosciences Quarterly
2019-08-09 10Q COGT/Cogent Biosciences Quarterly
2019-05-10 10Q COGT/Cogent Biosciences Quarterly

Receive COGT News And Ratings

See the #1 stock for the next 7 days that we like better than COGT

COGT Financial Statistics

Sales & Book Value

Annual Sales: $7.87M
Cash Flow: $-44.39M
Price / Cash Flow: 0
Annual Sales: $2.30
Price / Book: 3.2

Profitability

EPS (TTM): -2.41000
Net Income (TTM): $-192.41M
Gross Margin: $72.86M
Return on Equity: 0%
Return on Assets: 0%

Cogent Biosciences Earnings Forecast

Key Cogent Biosciences Financial Ratios

  • The Gross Profit Margin over the past 5 years for COGT is 871.53%.
  • The Selling, General & Administrative Expenses for COGT have been equal to 221.34% of Gross Profit Margin.
  • Per Share Earnings over the last 11 years have been positive in 3 years.

Cogent Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: COGT
CUSIP: 19240Q
Website: cogentbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

COGT Technical Analysis vs Fundamental Analysis

Sell
32
Cogent Biosciences (COGT) is a Sell

Is Cogent Biosciences a Buy or a Sell?